Table 3.

Oxidative stress markers

	NO	MDA	GSH	CAT
Control	11.21 ± 0.135b	37.85 ± 0.74b	0.215 ± 0.005b	0.582 ± 0.01b
	SEM ± 0.077	SEM ± 0.42	SEM ± 0.002	SEM ± 0.006
Cisplatin	24.25 ± 0.51a	85.8 ± 0.59a	0.129 ± 0.001a	0.386 ± 0.01a
	SEM ± 0.29	SEM ± 0.34	SEM ± 0.0008	SEM ± 0.006
SH 100	11.13 ± 0.57b	35.17 ± 0.43b	0.272 ± 0.007a,b	0.845 ± 0.014a,b
	SEM ± 0.32	SEM ± 0.25	SEM ± 0.004	SEM ± 0.008
SH 50	10.22 ± 0.53b	27.62 ± 0.72a,b	0.33 ± 0.003a,b	0.651 ± 0.01b
	SEM ± 0.3	SEM ± 0.41	SEM ± 0.002	SEM ± 0.006
SP 100	10.16 ± 0.28b	40.92 ± 0.69b	0.289 ± 0.004a,b	0.632 ± 0.007b
	SEM ± 0.17	SEM ± 0.40	SEM ± 0.002	SEM ± 0.004
SP 50	12.3 ± 0.355b	32.86 ± 0.36b	0.345 ± 0.006a,b	0.552 ± 0.008b
	SEM ± 0.20	SEM ± 0.21	SEM ± 0.003	SEM ± 0.004

Data is expressed as mean ± SD, and Standard error of the mean SEM

^aSignificantly different from the control group; p-value < 0.0001. ^bSignificantly different from the Cisplatin model group; p-value < 0.0001